Search Results - "Van Valkenburgh, Juno"

Refine Results
  1. 1

    Development of a novel radiofluorinated riboflavin probe for riboflavin receptor-targeting PET imaging by Li, Jindian, Valkenburgh, Juno Van, Fang, Jianyang, Zhang, Deliang, Chen, Yingxi, Chen, Quan, Jia, Guorong, Chen, Austin Z., Zhang, Xianzhong, Chen, Kai

    Published in Pharmacological research (01-09-2022)
    “…Riboflavin receptor 3 (RFVT3) is a key protein in energetic metabolism reprogramming and is overexpressed in multiple cancers involved in malignant…”
    Get full text
    Journal Article
  2. 2

    Small molecules as theranostic agents in cancer immunology by Li, Jindian, Van Valkenburgh, Juno, Hong, Xingfang, Conti, Peter S, Zhang, Xianzhong, Chen, Kai

    Published in Theranostics (01-01-2019)
    “…With further research into the molecular mechanisms and roles linking immune suppression and restraint of (pre)malignancies, immunotherapies have…”
    Get full text
    Journal Article Book Review
  3. 3

    Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma by Jia, Guorong, Van Valkenburgh, Juno, Chen, Austin Z., Chen, Quan, Li, Jindian, Zuo, Changjing, Chen, Kai

    “…Transarterial chemoembolization (TACE) is a recommended treatment for patients suffering from intermediate and advanced hepatocellular carcinoma (HCC). As…”
    Get full text
    Journal Article
  4. 4

    Understanding the Exchange of Systemic HDL Particles Into the Brain and Vascular Cells Has Diagnostic and Therapeutic Implications for Neurodegenerative Diseases by Van Valkenburgh, Juno, Meuret, Cristiana, Martinez, Ashley E., Kodancha, Vibha, Solomon, Victoria, Chen, Kai, Yassine, Hussein N.

    Published in Frontiers in physiology (06-09-2021)
    “…High-density lipoproteins (HDLs) are complex, heterogenous lipoprotein particles, consisting of a large family of apolipoproteins, formed in subspecies of…”
    Get full text
    Journal Article
  5. 5

    Activity and electrochemical properties: iron complexes of the anticancer drug triapine and its analogs by Plamthottam, Sheba, Sun, Daniel, Van Valkenburgh, Juno, Valenzuela, Jeffrey, Ruehle, Bastian, Steele, Dalton, Poddar, Soumya, Marshalik, Maxim, Hernandez, Selena, Radu, Caius Gabriel, Zink, Jeffrey I.

    Published in Journal of biological inorganic chemistry (01-08-2019)
    “…Triapine (3-AP), is an iron-binding ligand and anticancer drug that is an inhibitor of human ribonucleotide reductase (RNR). Inhibition of RNR by 3-AP results…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Monitoring DHA and AA Brain Uptake in ApoE4 Mice with 18 F‐Fluorinated PET Tracers by Duro, Marlon Vincent V., Van Valkenburgh, Juno S., Kerman, Bilal E., Wang, Shaowei, Liu, Xiaodan, Sta, Naomi, Zanderigo, Francesca, Jacobs, Russell E., Chen, Kai, Yassine, Hussein N.

    Published in Alzheimer's & dementia (01-12-2022)
    “…Abstract Background Polyunsaturated fatty acids (PUFAs) are the precursors of various lipid mediators of inflammation. Brain imaging techniques for monitoring…”
    Get full text
    Journal Article
  9. 9

    Monitoring DHA and AA Brain Uptake in ApoE4 Mice with 18F‐Fluorinated PET Tracers by Duro, Marlon Vincent V., Van Valkenburgh, Juno S., Kerman, Bilal E., Wang, Shaowei, Liu, Xiaodan, Sta, Naomi, Zanderigo, Francesca, Jacobs, Russell E., Chen, Kai, Yassine, Hussein N.

    Published in Alzheimer's & dementia (01-12-2022)
    “…Background Polyunsaturated fatty acids (PUFAs) are the precursors of various lipid mediators of inflammation. Brain imaging techniques for monitoring the…”
    Get full text
    Journal Article
  10. 10

    Inhibition of calcium‐dependent phospholipase A2 improves blood‐brain barrier integrity in ApoE4 carrying mice by Kerman, Bilal E., Duro, Marlon Vincent V., Maria, Naomi Sta, Liu, Xiaodan, Wang, Shaowei, Van Valkenburgh, Juno S., Chen, Kai, Jacobs, Russell E., Yassine, Hussein N.

    Published in Alzheimer's & dementia (01-12-2022)
    “…Background Blood‐brain barrier (BBB) is essential for neural health and function. Degradation of BBB is observed in Alzheimer’s disease (AD) and is more…”
    Get full text
    Journal Article
  11. 11
  12. 12

    EGFR Mutation Status and Subtypes Predicted by CT-Based 3D Radiomic Features in Lung Adenocarcinoma by Chen, Quan, Li, Yan, Cheng, Qiguang, Van Valkenburgh, Juno, Sun, Xiaotian, Zheng, Chuansheng, Zhang, Ruiguang, Yuan, Rong

    Published in OncoTargets and therapy (01-01-2022)
    “…In this study, we aim to establish a non-invasive tool to predict epidermal growth factor receptor (EGFR) mutation status and subtypes based on radiomic…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Exploring Solvent Effects in the Radiosynthesis of 18 F-Labeled Thymidine Analogues toward Clinical Translation for Positron Emission Tomography Imaging by Li, Jindian, Van Valkenburgh, Juno, Conti, Peter S, Chen, Kai

    Published in ACS pharmacology & translational science (12-02-2021)
    “…Thymidine analogues, 5-substituted 2'-deoxy-2'-[ F]fluoro-arabinofuranosyluracil derivatives, are promising positron emission tomography (PET) tracers being…”
    Get full text
    Journal Article
  15. 15

    Exploring Solvent Effects in the Radiosynthesis of 18F‑Labeled Thymidine Analogues toward Clinical Translation for Positron Emission Tomography Imaging by Li, Jindian, Van Valkenburgh, Juno, Conti, Peter S, Chen, Kai

    Published in ACS pharmacology & translational science (12-02-2021)
    “…Thymidine analogues, 5-substituted 2′-deoxy-2′-[18F]­fluoro-arabinofuranosyluracil derivatives, are promising positron emission tomography (PET) tracers being…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Development of Small-Molecule Modulators of Nucleotide Metabolism Enzymes by Van Valkenburgh, Juno Simone

    Published 01-01-2019
    “…In chapter 1, strategies toward the asymmetric synthesis of a deoxycytidine kinase (dCK) inhibitor are presented. Small molecule dCK inhibitors are potential…”
    Get full text
    Dissertation
  18. 18
  19. 19
  20. 20